Bio89-100

3 trials 2 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

1 Sponsors

12 Countries

Phase III

Phase III: 3

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Sponsors using this IMP

All trials

3 total

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting

2023-509912-27-00 Phase III 10 countries 89bio Inc.
Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH (ENLIGHTEN-Cirrhosis) Recruiting

2023-510395-31-00 Phase III 9 countries 89bio Inc.
A Ph3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Severe Hypertriglyceridemia: The ENTRUST study Ended

2023-503576-25-00 Phase III 11 countries 89bio Inc.

Showing 1–3 of 3 trials

← All drugs A–Z